Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felicia Cosman

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
Bonekey Reports|May 20, 2015
Abaloparatide: a new anabolic therapy on the horizonFelicia Cosman
Clinics in Geriatric Medicine|August 15, 2003
Selective estrogen-receptor modulatorsFelicia Cosman
Current Opinion in Endocrinology, Diabetes, and Obesity|October 31, 2008
Parathyroid hormone treatment for osteoporosisFelicia Cosman
Bonekey Reports|May 6, 2014
Combination therapy for osteoporosis: a reappraisalFelicia Cosman
Current Osteoporosis Reports|November 24, 2005
Anabolic therapy for osteoporosis: parathyroid hormoneFelicia Cosman
Current Osteoporosis Reports|July 23, 2005
Therapeutic potential of parathyroid hormoneFelicia Cosman, Robert Lindsay
Current Osteoporosis Reports|February 26, 2021
Anabolic Agents for Postmenopausal Osteoporosis: How Do You Choose?Felicia Cosman, David W Dempster
Current Osteoporosis Reports|April 29, 2010
Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonatesJeri W Nieves, Felicia Cosman
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 4, 2024
Treatment Sequence for OsteoporosisFelicia Cosman, Bente Langdahl, Benjamin Z Leder
The Lancet. Diabetes & Endocrinology|June 16, 2026
Treatment duration for romosozumabMichael R McClung, David Dempster, Felicia Cosman
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
Bonekey Reports|May 20, 2015
Abaloparatide: a new anabolic therapy on the horizonFelicia Cosman
Clinics in Geriatric Medicine|August 15, 2003
Selective estrogen-receptor modulatorsFelicia Cosman
Current Opinion in Endocrinology, Diabetes, and Obesity|October 31, 2008
Parathyroid hormone treatment for osteoporosisFelicia Cosman
Bonekey Reports|May 6, 2014
Combination therapy for osteoporosis: a reappraisalFelicia Cosman
Current Osteoporosis Reports|November 24, 2005
Anabolic therapy for osteoporosis: parathyroid hormoneFelicia Cosman
Current Osteoporosis Reports|July 23, 2005
Therapeutic potential of parathyroid hormoneFelicia Cosman, Robert Lindsay
Current Osteoporosis Reports|February 26, 2021
Anabolic Agents for Postmenopausal Osteoporosis: How Do You Choose?Felicia Cosman, David W Dempster
Current Osteoporosis Reports|April 29, 2010
Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonatesJeri W Nieves, Felicia Cosman
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 4, 2024
Treatment Sequence for OsteoporosisFelicia Cosman, Bente Langdahl, Benjamin Z Leder
The Lancet. Diabetes & Endocrinology|June 16, 2026
Treatment duration for romosozumabMichael R McClung, David Dempster, Felicia Cosman
Pageof 12